ArticleInvestigational new drugs2015

A phase I trial of combination trastuzumab, lapatinib, and bevacizumab in patients with advanced cancer.

Gerald S Falchook et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.